A phase I/II study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metastases (ADORATION).
Article
Kotecha, Rupesh, Odia, Yazmin, Chen, Zhijian et al. (2024). A phase I/II study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metastases (ADORATION).
. JOURNAL OF CLINICAL ONCOLOGY, 42(16_suppl), tps2093-tps2093. 10.1200/jco.2024.42.16_suppl.tps2093
Kotecha, Rupesh, Odia, Yazmin, Chen, Zhijian et al. (2024). A phase I/II study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metastases (ADORATION).
. JOURNAL OF CLINICAL ONCOLOGY, 42(16_suppl), tps2093-tps2093. 10.1200/jco.2024.42.16_suppl.tps2093